Radovanović Stojanović & Partners advises on the sale of Emily Pharm
Radovanović Stojanović & Partners ranked in IFLR1000
14/09/2023
GTCs in the Digital Age
02/11/2023Radovanović Stojanović & Partners has advised the shareholders of Emily Pharm on the sale of all their respective shares to the Dr. Max Group.
Radovanović Stojanović & Partners has advised the shareholders of Emily Pharm on the sale of all their respective shares to the Dr. Max Group.
Emily Pharm is a pharmacy chain based in Belgrade, Serbia. The Dr. Max Group is a Prague-headquartered pharmacy chain operating in Central and Eastern Europe. The group has approximately 2,300 pharmacies in the Czech Republic, Serbia, Slovakia, Poland, Romania and Italy.
The RSP team was led by Saša Stojanović and also involved Luka Radojević and Đorđe Vićić.
